Jubilant HollisterStier Secures Significant Contracts
Jubilant HollisterStier, a subsidiary of Jubilant Life Sciences, recently announced its Contract Manufacturing & Services division has recently secured over $100 million in contracts with leading pharmaceutical companies for the commercial manufacturing of multiple sterile parenteral products. These awards are the continuation of existing relationships and will be executed across both parenteral manufacturing locations in Spokane WA, and Montreal Canada. The commercial technology transfer efforts are expected to commence in 2013.
“We are excited to expand our existing strategic commercial relationships, and will bring forward our capabilities in manufacturing excellence, rigorous quality oversight, and project management to support a smooth and timely transfer to our manufacturing locations, said Jubilant HollisterStier Chief Executive Officer, Marcelo Morales.
Jubilant HollisterStier Contract Manufacturing & Services Division is a subsidiary of Jubilant Life Sciences, an integrated pharma and life sciences company headquartered in India. Jubilant HollisterStier provides its customers manufacturing services to aseptically fill liquid and lyophilized products, semi-solid, and solid dosage forms at its facilities in the US, Canada, and India. Jubilant HollisterStier offers highly skilled, cross-functional teams to provide custom solutions to customer-specific project goals from development through commercialization. Jubilant HollisterStier is committed to providing exceptional quality, regulatory expertise and operational excellence to ensure streamlined processes and services in all facilities. For more information, visit www.jublHS.com.
Total Page Views: 1253
